Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123111572 | 12311157 | 2 | F | 20140215 | 20160621 | 20160427 | 20160706 | EXP | DK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-031470 | BRISTOL MYERS SQUIBB | 59.00 | YR | M | Y | 0.00000 | 20160706 | MD | DK | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123111572 | 12311157 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 10 MG, QD | 4135 | MG | Y | 21436 | 10 | MG | QD | ||||
| 123111572 | 12311157 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 15 MG, QD | 4135 | MG | Y | 21436 | 15 | MG | QD | ||||
| 123111572 | 12311157 | 3 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 5 MG/KG, QD | 4135 | MG | Y | 21436 | 5 | MG/KG | QD | ||||
| 123111572 | 12311157 | 4 | C | LEPONEX | CLOZAPINE | 1 | Oral | 300 MG, QD | U | 0 | 300 | MG | QD | ||||||
| 123111572 | 12311157 | 5 | C | PAROXETINE. | PAROXETINE | 1 | Unknown | 10 MG, UNK | U | 0 | 10 | MG | |||||||
| 123111572 | 12311157 | 6 | C | RANITIC | RANITIDINE HYDROCHLORIDE | 1 | Unknown | 300 MG, QD | U | 0 | 300 | MG | QD | ||||||
| 123111572 | 12311157 | 7 | C | JODETTEN | 2 | Unknown | 200 ?G, QD | U | 0 | 200 | UG | QD | |||||||
| 123111572 | 12311157 | 8 | C | AMISULPRIDE | AMISULPRIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123111572 | 12311157 | 1 | Product used for unknown indication |
| 123111572 | 12311157 | 4 | Product used for unknown indication |
| 123111572 | 12311157 | 5 | Product used for unknown indication |
| 123111572 | 12311157 | 6 | Product used for unknown indication |
| 123111572 | 12311157 | 7 | Product used for unknown indication |
| 123111572 | 12311157 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123111572 | 12311157 | OT |
| 123111572 | 12311157 | LT |
| 123111572 | 12311157 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123111572 | 12311157 | Extrapyramidal disorder | |
| 123111572 | 12311157 | Psychotic disorder | |
| 123111572 | 12311157 | Restlessness | |
| 123111572 | 12311157 | Suicidal ideation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123111572 | 12311157 | 1 | 20130101 | 20140210 | 0 | |
| 123111572 | 12311157 | 2 | 20140211 | 20140215 | 0 | |
| 123111572 | 12311157 | 3 | 20140216 | 20140217 | 0 | |
| 123111572 | 12311157 | 4 | 1995 | 0 | ||
| 123111572 | 12311157 | 5 | 2012 | 20140210 | 0 |